The billionaire founder of Insys Therapeutics, Inc. has resigned, following his arrest last week on federal racketeering and conspiracy charges related to the marketing of the company’s opioid painkiller, Subsys spray. What is Subsys Spray? John Kapoor founded Insys in … Continue reading
A recently-published analysis involving the U.S. Food & Drug Administration’s (FDA) adverse event database suggests that a new class of Type 2 diabetes drugs called SGLT 2 inhibitors may be associated with acute renal failure, a complication alleged in a … Continue reading
A plaintiff who allegedly developed heart failure due to Onglyza has filed a petition with the U.S. Judicial Panel on Multidistrict Litigation requesting that all such federal claims be transferred to the U.S. District Court, Northern District of California for … Continue reading
Hundreds of proton pump inhibitors lawsuits continue to move forward in the U.S. District Court, District of New Jersey, where all federally-filed claims involving the alleged potential for Nexium, Prilosec and PrevAcid to cause kidney failure and other life-threatening renal … Continue reading
A new hernia mesh lawsuit has been filed against Covidien, Inc., accusing the company of concealing and downplaying the risks allegedly associated with its Parietex Mesh Composite device. Parietex Mesh Lawsuit Allegations According to a complaint filed in the U.S. … Continue reading
The multidistrict litigation established last year for all federally-filed Invokana lawsuits continues to grow, with dozens of new cases added to the proceeding in just the past month alone. According to an October 12th Case Management Order, 865 cases are … Continue reading
The federal court overseeing hundreds of kidney injury lawsuits involving Nexium and other proton pump inhibitors convened its most recent Status Conference on October 11, 2017. According to a Joint Status Report prepared by the parties ahead of the conference, … Continue reading
The City Attorney for Los Angeles has launched a new investigation, following broadcast of a CNN report detailing the rising use of Nuedexta among elderly nursing home patients, especially in Southern California. According to the cable network, Mark Feuer is … Continue reading
Peripheral neuropathy lawsuits involving Avelox, Cipro and Levaquin continue to move forward in the multidistrict litigation currently underway in the U.S. District Court, District of Minnesota. According to an Order dated October 12th, the Court has amended the pretrial schedule … Continue reading